HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., (“Regentis” or the “Company”) (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair ...
$7.4 million in cash expected to provide runway to complete site expansion process and patient enrollment as part of ...
2 years after treatment, GelrinC-treated patients demonstrated layered cartilage architecture similar to native hyaline cartilage – widely regarded as the gold standard for durable joint function This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results